Ultrahuman Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.80 M
- Paid Up Capital ₹ 0.73 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 231.73%
- Profit Growth 1.57%
- Ebitda 0.10%
- Net Worth -10.16%
- Total Assets 4.19%
About Ultrahuman Healthcare
Ultrahuman Healthcare Private Limited (UHPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 November 2019 (Five years and three months 23 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.80 M and a paid-up capital of Rs 0.73 M, as per Ministry of Corporate Affairs (MCA) records.
Abhilasha Bhatnagar, Matthew Brooklyn, Vatsal Singhal, and One other member serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U74999KA2019PTC129250
- Company No.
129250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ultrahuman Healthcare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhilasha Bhatnagar | Additional Director | 27-Mar-2024 | Current |
Matthew Brooklyn  | Nominee Director | Current | |
Vatsal Singhal  | Director | 01-Nov-2019 | Current |
| Mohit Kumar | Director | 01-Nov-2019 | Current |
Financial Performance of Ultrahuman Healthcare.
Ultrahuman Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 231.73% increase. The company also saw a slight improvement in profitability, with a 1.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultrahuman Healthcare?
In 2023, Ultrahuman Healthcare had a promoter holding of 99.70% and a public holding of 0.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ultrahuman Healthcare?
Ultrahuman Healthcare has a workforce of 85 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultrahuman Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultrahuman Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
